XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.3
EARNINGS (LOSS) PER SHARE (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS

The following calculates basic and diluted EPS from operations:

 

   Three Months   Three Months 
   Ended   Ended 
   September 30, 2025   September 30, 2024 
Loss from continuing operations  $(1,156,583)  $(837,314)
Net loss continuing operations, numerator, basic computation   (1,156,583)   (837,314)
Recognition and change in fair value of warrant liabilities   -    - 
Net loss from continuing operations, numerator, diluted computation  $(1,156,583)  $(837,314)
           
Weighted average common shares, basic   5,826,995    1,252,799 
Weighted average common shares, dilutive   5,826,995    1,252,799 
Loss per common share – basic  $(0.20)  $(0.67)
Loss per common share – diluted  $(0.20)  $(0.67)

 

   Nine Months   Nine Months 
   Ended   Ended 
   September 30, 2025   September 30, 2024 
Loss from continuing operations  $(5,604,367)  $(7,673,373)
Net Loss continuing operations, numerator, basic computation   (5,604,367)   (7,673,373)
Recognition and change in fair value of warrant liabilities   -    - 
Net loss from continuing operations, numerator, diluted computation  $(5,604,367)  $(7,673,373)
           
Weighted average common shares, basic   3,891,166    726,347 
Weighted average common shares, dilutive   3,891,166    726,347 
Loss per common share – basic  $(1.44)  $(10.56)
Loss per common share – diluted  $(1.44)  $(10.56)
SCHEDULE OF DILUTIVE NET LOSS PER COMMON SHARE

Additionally, the following are considered anti-dilutive securities excluded from weighted-average shares used to calculate diluted net loss per common share for the three and nine month periods ended:

 

   September 30, 2025   September 30, 2024 
Shares subject to outstanding common stock options   -    50 
Shares subject to outstanding Series A warrants   6,647    6,647 
Shares subject to outstanding PAW’s   959    959 
Shares subject to PA Warrants   3,096    3,096 
Shares subject to Outstanding Series J Warrants
   2,976,192    - 
Shares subject to Outstanding Series J PAW’s   104,167    - 
Shares subject to unvested stock awards   142,747    52